BREAKTHROUGH-THERAPY-DESIGNATION

BREAKTHROUGH-THERAPY-DESIGNATION

Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001

Aurion Biotech, a pioneering biotechnology company, has made a significant stride in the field of regenerative medicine. The company has recently received two prestigious designations from the U.S. Food and Drug Administration (FDA): Breakthrough Therapy Designation (BTD) and Regenerative Medicine Advanced Therapy (RMAT) Designation..

BREAKTHROUGH-THERAPY-DESIGNATION

Sunvozertinib Granted Breakthrough Therapy Designation by China CDE for the First-Line Treatment of Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

A New Hope in Cancer Treatment: Sunvozertinib’s Breakthrough Designation for EGFRPositive NSCLC In a significant development in the fight against nonsmall cell lung cancer (NSCLC), the China Center ..